School of Medicine

Researchers at WashU Medicine have developed a nasal vaccine against the highly pathogenic H5N1 avian influenza virus, or bird flu, which has jumped from wild birds to farm animals to humans. In rodents, the vaccine elicited a strong immune response and prevented infections in H5N1-exposed animals.

An antibody-based immunotherapy reduces plaque in the arteries of mice, offering a potential new strategy to treat cardiovascular disease, according to a study led by WashU Medicine researchers.

Thomas Kannampallil, chief data scientist and assistant dean for data science at WashU Medicine, and Laura Wiley, an associate professor of neurology at WashU Medicine, have been named 2025 American College of Medical Informatics fellows.

WashU Medicine construction projects will temporarily affect pedestrian traffic around Ellen S. Clark Hope Plaza and Wohl Circle. Also, the Bridge Renewal project to repair water infiltration in the tunnels and utilities below campus enters a new phase.

A multi-center study led by researchers at WashU Medicine and Michigan Medicine found that breathing problems during sleep are widespread among newborns with a severe form of spina bifida and could be a promising target for early interventions to improve the babies’ neurodevelopment.

Researchers at WashU Medicine and Children’s Hospital of Philadelphia have shown that disease-associated bacteria in the gut can be detected through exhaled breath. The findings could pave the way for a rapid, non-invasive breath test to assess gut microbiome health.

Samuel Klein, MD, the William H. Danforth Professor of Medicine and Nutritional Science at WashU Medicine, has received the Endocrine Society’s Outstanding Clinical Investigator Award.

Washington University in St. Louis has been recognized as a Focused Ultrasound Center of Excellence by the Focused Ultrasound Foundation.

Donald “Don” E. Clayton, a former associate vice chancellor of Medical Public Affairs at WashU Medicine, died Jan. 8 after a respiratory illness. He was 71.

In a new study, WashU Medicine researchers show that vagus nerve stimulation provides substantial, long-lasting relief to some people with the most severe treatment-resistant depression.